Publisher
Springer Science and Business Media LLC
Reference33 articles.
1. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2013) GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11 [Internet]. International Agency for Research on Cancer, Lyon
2. Deo SV, Bhutani M, Shukla NK, Raina V, Rath GK, Purkayasth J (2003) Randomized trial comparing neo-adjuvant versus adjuvant chemotherapy in operable locally advanced breast cancer (T4b N0-2 M0). J Surg Oncol 84:192–197
3. Charfare H, Limongelli S, Purushotham AD (2005) Neoadjuvant chemotherapy in breast cancer. Br J Surg 92:14–23
4. Heys SD, Chaturvedi S (2003) Primary chemotherapy in breast cancer: the beginning of the end or end of the beginning for the surgical oncologist? World J Surg Oncol 1(1):14
5. Chintamani, Singhal V, Singh JP, Lyall A, Saxena S, Bansal A (2004) Is drug induced toxicity a good predictor of response to neoadjuvant chemotherapy in patients with breast cancer? – a prospective clinical study. BMC Cancer 4:48
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献